LONGBOARD PHARMACEUTICALS
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases. Its proprietary pipeline includes multiple programs with broad clinical utility. Longboard is evaluating LP352, a next-generation 5-HT2C agonist, in development for the potential treatment of developmental and epileptic encephalopathies, or DEEs. Longboard is also evaluating LP143, a centrally acting, full agonist of the cannabinoid type 2 receptor (CB2), and LP659, a centrally acting, next-generation, highly selective S1P receptor modulator.
LONGBOARD PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.longboardpharma.com
Total Employee:
11+
Status:
Active
Contact:
(619) 592-9775
Email Addresses:
[email protected]
Total Funding:
56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Aileens Pharma
Aileens Pharma is adeveloper of treatments to improve clinical outcomes in patients suffering from dermatological diseases.
Concours Pharmaceuticals
Concours Pharmaceuticals leverages its proprietary oral delivery platform for pharmaceutical development.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Lennham Pharmaceuticals
Lennham Pharmaceuticals is dedicated to improving the metabolic and pharmacological profile of drugs through deuterium chemistry.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Longboard Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Longboard Pharmaceuticals
Farallon Capital Management
Farallon Capital Management investment in Series A - Longboard Pharmaceuticals
Highline Capital Management
Highline Capital Management investment in Series A - Longboard Pharmaceuticals
T. Rowe Price
T. Rowe Price investment in Series A - Longboard Pharmaceuticals
Official Site Inspections
http://www.longboardpharma.com Semrush global rank: 9.44 M Semrush visits lastest month: 156
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Longboard Pharmaceuticals"
Home - Longboard Pharmaceuticals
Longboard is leveraging 20 years of research to develop the next generation of GPCR-targeted medicines. Longboard Life. We are committed to improving the quality of life for individuals …See details»
About - Longboard Pharmaceuticals
Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, with an initial focus on rare diseases.See details»
Longboard Life - Longboard Pharmaceuticals
We are committed to improving the quality of life for individuals with devastating neurological conditions. Our team works together to create a company culture and welcoming environment …See details»
Investors | Longboard Pharmaceuticals
Mar 12, 2021 · Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard …See details»
Longboard Pharmaceuticals - LinkedIn
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard is working to advance a...See details»
Longboard Pharmaceuticals - Crunchbase Company Profile
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases. View contacts for Longboard …See details»
Acquisition of Longboard Pharmaceuticals
FDA has granted Breakthrough Therapy Designation. Expected launch in the fourth quarter of 2028. Global peak sales potential estimated at USD 1.5-2 billion, complementing our mid- to …See details»
Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic …
Oct 14, 2024 · Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline. Oct 14, 2024 . PDF Version. A global phase III trial …See details»
Longboard Pharmaceuticals Reports Full Year 2023 Financial …
Mar 12, 2024 · Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard …See details»
Culture and Benefits - Longboard Pharmaceuticals
We are pleased to offer a comprehensive array of valuable benefits to protect the health of our employees, their families and their way of life. We are committed to having an enjoyable work …See details»
Kevin Lind - President & CEO at Longboard Pharmaceuticals - The …
Mr. Lind has over 20 years of experience in the life sciences industry. Prior to joining Longboard Pharmaceuticals, Mr. Lind served as Executive Vice President and Chief Financial Officer of …See details»
Longboard Pharmaceuticals - Craft
Jun 24, 2024 · Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. It specializes in …See details»
Patients - Longboard Pharmaceuticals
At Longboard, we are committed to providing personalized support services throughout a patient and caregiver’s journey.See details»
Longboard Pharmaceuticals to Present at Three Upcoming …
Nov 1, 2023 · Live webcasts of the presentations will be available on the “Events & Presentations” page within the Investors Relations section of Longboard’s website at …See details»
Longboard Pharmaceuticals - Overview, News & Similar
Jul 16, 2024 · Longboard Pharmaceuticals contact info: Phone number: (858) 789-9283 Website: www.longboardpharma.com What does Longboard Pharmaceuticals do? Longboard …See details»
Longboard Pharmaceuticals Announces Commencement of Public …
Jan 2, 2024 · Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard …See details»
Our Approach - Longboard Pharmaceuticals
Longboard was formed in January 2020 by Arena Pharmaceuticals, Inc. (acquired by Pfizer) to advance a portfolio of centrally-acting product candidates designed to be highly selective for …See details»
News Release Details - ir.longboardpharma.com
Sep 26, 2024 · First sites activated with a number of additional rapid-start sites being activated in the coming weeks; LA JOLLA, Calif.--(BUSINESS WIRE)--Sep. 26, 2024-- Longboard …See details»
Longboard Pharmaceuticals Announces Closing of Public Offering …
Oct 11, 2022 · Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard …See details»
Longboard Pharmaceuticals to Present Late-Breaking Data from …
Apr 3, 2024 · Longboard is conducting a Phase 1 single-ascending dose (SAD) clinical trial for LP659 in healthy volunteers, with topline data expected in the second quarter of 2024. Certain …See details»